当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 现金流量表

华东医药

(000963)

  

流通市值:799.41亿  总市值:800.39亿
流通股本:17.52亿   总股本:17.54亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金23,043,949,397.089,882,552,619.7243,401,956,267.833,334,628,825.63
  收到的税费返还5,110,647.252,055,460.5511,647,283.2515,628,115.69
  收到其他与经营活动有关的现金311,722,673.58230,013,343.261,556,579,035.21566,037,648.66
  经营活动现金流入小计23,360,782,717.9110,114,621,423.5344,970,182,586.2633,916,294,589.98
  购买商品、接受劳务支付的现金13,943,183,727.917,695,820,108.3128,195,403,709.5121,947,910,270.08
  支付给职工以及为职工支付的现金2,692,040,129.251,441,219,423.874,755,191,780.743,446,050,305.28
  支付的各项税费1,576,435,543.9671,816,951.082,574,487,192.251,962,213,221.83
  支付其他与经营活动有关的现金2,692,274,806.751,138,493,634.155,696,171,021.414,053,717,983.88
  经营活动现金流出小计20,903,934,207.8110,947,350,117.4141,221,253,703.9131,409,891,781.07
  经营活动产生的现金流量净额2,456,848,510.1-832,728,693.883,748,928,882.352,506,402,808.91
二、投资活动产生的现金流量:
  收回投资收到的现金--1,000,0001,000,000
  取得投资收益收到的现金47,347,567.6743,350,00045,230,192.9845,200,000
  处置固定资产、无形资产和其他长期资产收回的现金净额10,814,966.499,751,90719,759,145.852,528,623.35
  收到的其他与投资活动有关的现金--261,016,721.64263,981,767.12
  投资活动现金流入小计58,162,534.1653,101,907327,006,060.47312,710,390.47
  购建固定资产、无形资产和其他长期资产支付的现金788,358,827.36637,322,382.411,727,864,860.12930,485,860.82
  投资支付的现金61,560,77561,618,92569,176,613.4152,360,852.87
  取得子公司及其他营业单位支付的现金--461,958,981.61348,814,981.61
  支付其他与投资活动有关的现金--238,277,274.34485,504,341.65
  投资活动现金流出小计849,919,602.36698,941,307.412,497,277,729.471,917,166,036.95
  投资活动产生的现金流量净额-791,757,068.2-645,839,400.41-2,170,271,669-1,604,455,646.48
三、筹资活动产生的现金流量:
  取得借款收到的现金1,720,372,646.921,289,998,8484,559,775,187.363,543,115,046.17
  收到其他与筹资活动有关的现金217,401,111.1146,000,000690,739,328.24343,706,321.33
  筹资活动现金流入小计1,937,773,758.021,435,998,8485,250,514,515.63,886,821,367.5
  偿还债务支付的现金1,728,740,028.91,279,708,605.453,571,431,254.372,930,078,520.91
  分配股利、利润或偿付利息支付的现金1,057,608,222.2517,579,298.661,733,453,239.021,751,880,188.48
  其中:子公司支付给少数股东的股利、利润--31,275,554.965,994,660
  支付其他与筹资活动有关的现金684,856,705.37225,549,581.73695,294,341.33366,279,261.77
  筹资活动现金流出小计3,471,204,956.521,522,837,485.846,000,178,834.725,048,237,971.16
  筹资活动产生的现金流量净额-1,533,431,198.5-86,838,637.84-749,664,319.12-1,161,416,603.66
四、汇率变动对现金及现金等价物的影响-116,843,004.4-3,115,685.5-47,001,718.4621,363,561.91
五、现金及现金等价物净增加额14,817,239-1,568,522,417.63781,991,175.77-238,105,879.32
  加:期初现金及现金等价物余额4,990,151,186.684,990,151,186.684,208,160,010.914,208,160,010.91
  期末现金及现金等价物余额5,004,968,425.683,421,628,769.054,990,151,186.683,970,054,131.59
补充资料:
  净利润1,803,329,008.97-3,494,185,631.76-
  资产减值准备83,959,366.71-153,185,473.56-
  固定资产和投资性房地产折旧300,346,213.46-473,271,554.08-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧300,346,213.46-473,271,554.08-
  无形资产摊销210,989,400.4-291,077,823.5-
  长期待摊费用摊销4,929,866.34-9,728,874.68-
  处置固定资产、无形资产和其他长期资产的损失6,201,002.36-5,463,399.18-
  固定资产报废损失1,867,728.04-2,033,665.48-
  公允价值变动损失0-0-
  财务费用55,530,243.83-87,246,657.66-
  投资损失35,365,772.99-82,799,888.43-
  递延所得税-35,858,881.65--49,278,116.87-
  其中:递延所得税资产减少-35,423,070.01--33,855,364.93-
    递延所得税负债增加-435,811.64--15,422,751.94-
  存货的减少-253,462,220.69--498,851,129.33-
  经营性应收项目的减少-517,861,553.48--1,979,535,459.83-
  经营性应付项目的增加758,867,410.03-1,565,935,497.69-
  其他2,645,152.79-20,980,024.57-
  现金的期末余额5,004,968,425.68-4,990,151,186.68-
  减:现金的期初余额4,990,151,186.68-4,208,160,010.91-
  加:现金等价物的期末余额0-0-
  减:现金等价物的期初余额0-0-
  现金及现金等价物的净增加额14,817,239-781,991,175.77-
公告日期2025-08-202025-04-252025-04-182024-10-25
审计意见(境内)标准无保留意见
TOP↑